Evidence map›Paper›PMID 35646648›Full record

ArticleFrontiers in oncology2022

XGBG: A Novel Method for Identifying Ovarian Carcinoma Susceptible Genes Based on Deep Learning.

Ke Feng Sun, Li Min Sun, Dong Zhou, Ying Ying Chen, Xi Wen Hao, Hong Ruo Liu, Xin Liu, Jing Jing Chen

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 1 country.

Ke Feng SunDepartment of Obstetrics and Gynecology, First Affiliated Hospital, Heilongjiang University of Chinese Medicine, Harbin, China.
Li Min SunDepartment of Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Dong ZhouDepartment of Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
Ying Ying ChenDepartment of Nephrology, The First Affiliated Hospital of Heilongjiang University of Chinese Medical, Harbin, China.
Xi Wen HaoHeilongjiang University of Chinese Medicine, Harbin, China.
Hong Ruo LiuDepartment of Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Xin LiuDepartment of Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Jing Jing ChenDepartment of Rheumatology and Immunology, The First Hospital Affiliated to Army Medical University, Chongqing, China.
First Affiliated Hospital of Heilongjiang University of Chinese Medicine · CNSecond Affiliated Hospital of Dalian Medical University · CNAffiliated Zhongshan Hospital of Dalian University · CNArmy Medical University · CNDalian Medical University · CNHeilongjiang University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovarian carcinomas (OCs) represent a heterogeneous group of neoplasms consisting of several entities with pathogenesis, molecular profiles, multiple risk factors, and outcomes. OC has been regarded as the most lethal cancer among women all around the world. There are at least five main types of OCs classified by the fifth edition of the World Health Organization of tumors: high-/low-grade serous carcinoma, mucinous carcinoma, clear cell carcinoma, and endometrioid carcinoma. With the improved knowledge of genome-wide association study (GWAS) and expression quantitative trait locus (eQTL) analyses, the knowledge of genomic landscape of complex diseases has been uncovered in large measure. Moreover, pathway analyses also play an important role in exploring the underlying mechanism of complex diseases by providing curated pathway models and information about molecular dynamics and cellular processes. To investigate OCs deeper, we introduced a novel disease susceptible gene prediction method, XGBG, which could be used in identifying OC-related genes based on different omics data and deep learning methods. We first employed the graph convolutional network (GCN) to reconstruct the gene features based on both gene feature and network topological structure. Then, a boosting method is utilized to predict OC susceptible genes. As a result, our model achieved a high AUC of 0.7541 and an AUPR of 0.8051, which indicates the effectiveness of the XGPG. Based on the newly predicted OC susceptible genes, we gathered and researched related literatures to provide strong support to the results, which may help in understanding the pathogenesis and mechanisms of the disease.

Indexed as

deep learningovarian cancerpathway analysessusceptible genesXGBG

Identifiers

PMID35646648
PMCPMC9133413
OpenAlexW4280585058

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.